Zealand Pharma A/S at its Annual General Meeting of 2024 held on March 20, 2024, approved the following were elected as new members of the Board of Directors in accordance with the recommendation of the Nomination Committee (replacing Alain Munoz and Michael John Owen who did not stand for re-election): Elaine Sullivan and Enrique Conterno Martinelli. The Audit Committee will comprise Martin Nicklasson, Bernadette Mary Connaughton, and Jeffrey Berkowitz, with Leonard Kruimer chairing the Committee. The Remuneration Committee will compromise Enrique Conterno Martinelli and Leonard Kruimer, with Martin Nicklasson chairing the Committee.

The Scientific Committee will compromise Elaine Sullivan and Enrique Conterno Martinelli, with Kirsten Aarup Drejer chairing the Committee. The Nomination Committee will compromise Leonard Kruimer and Martin Nicklasson, with Kirsten Aarup Drejer chairing the Committee.